SCHEMBL4917682

SCHEMBL4917682

O=C(O)c1ccc(=O)n(CCOc2ccccc2)c1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PKM P14618 1/20 0.57
PTGDR2 Q9Y5Y4 1/20 0.52
KDM6B O15054 1/20 0.48
KDM5C P41229 1/20 0.48
KDM2A Q9Y2K7 1/20 0.48
KDM3A Q9Y4C1 1/20 0.48
KCNA5 P22460 3/20 0.48
LTA4H P09960 1/20 0.48
L3MBTL1 Q9Y468 2/20 0.47
PARP10 Q53GL7 1/20 0.46
MEN1 O00255 2/20 0.46
KMT2A Q03164 2/20 0.46
ALDH1A1 P00352 2/20 0.46
SMN1; SMN2 Q16637 2/20 0.46
GAA P10253 1/20 0.46
CYP2C9 P11712 1/20 0.46
HPGD P15428 1/20 0.46
CYP2C19 P33261 1/20 0.46
HTT P42858 1/20 0.46
TSHR P16473 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14034358 0.85 BRD4 (0.62) PKMPTGDR2KCNA5LTA4HL3MBTL1
SCHEMBL14007193 0.83 EPHX2 (0.52) PTGDR2KCNA5LTA4HL3MBTL1TSHR
SCHEMBL4248991 0.80 ALDH1A1 (0.51) ALDH1A1SMN1; SMN2GAAMAPTEPHX2
SCHEMBL14007242 0.78 EPHX2 (0.76) PTGDR2MEN1KMT2ASMN1; SMN2CYP2C9
SCHEMBL4665263 0.77 BRD4 (0.51) KDM6BKDM5CKDM2AKDM3AMEN1
SCHEMBL4251833 0.76 BRD4 (0.42) L3MBTL1ALDH1A1SMN1; SMN2GAATSHR
SCHEMBL20726668 0.75 PARP10 (0.51) KCNA5L3MBTL1PARP10ALDH1A1SMN1; SMN2
SCHEMBL89177 0.75 ALDH1A1 (0.46) ALDH1A1SMN1; SMN2GAAHTTEPHX2
SCHEMBL3161296 0.74 L3MBTL1 (0.45) L3MBTL1ALDH1A1SMN1; SMN2GAAHPGD
SCHEMBL1285278 0.73 PKM (1.00) PKML3MBTL1PARP10ALDH1A1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080280904-A1 N-Substituted Pyridinone or Pyrimidinone Compounds Useful as Soluble Epoxide Hydrolase Inhibitors ELDRUP ANNE BETTINA 2008-11-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080280904-A1 N-Substituted Pyridinone or Pyrimidinone Compounds Useful as Soluble Epoxide Hydrolase Inhibitors EPHX1, EPHX2, DOHH PKM 1847/4885PTGDR2 326/4885KDM6B 882/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.